Nanoligent obtains the first prize in the Tech Transfer Competition in the ONCO Emergence forum
Last June 21-22th, took place at the Fira Gran Via in Barcelona, the ONCO Emergence forum, a networking conference focused on setting up transnational collaboration projects in oncology by promoting interaction among research institutes, companies and medical facilities like hospitals.
In other to promote alliances and generate collaborative projects from hospitals and academia to other stakeholders, ONCO Emergence Forum Barcelona has created a Tech Transfer Competition that features cherry-picked entrepreneurs, TTO or principal investigators developing new technology ready to be licensed or in development through a spin-off. Selected participants presented their innovative projects in a 6-minute English pitch to an experienced panel of judges, being the prize €1,500, provided by Fundación Pública Andaluza Parque Tecnológico de la Salud de Granada. The competition target are therapeutic, diagnostic, medtech and digital health projects in oncology within the framework of improving healthcare and medical assistance with a deep focus on an unmet medical/market/patient need, resolved through an innovative technology to create a product or service; project must be in TLR 2-4 with tested hypothesis and demonstrated proof-of-concept as well as safety in in vitro/animal model.
NANOLIGENT, the spin off created by the Directors of NANBIOSIS Units U1. Protein Production Platform (PPP), Antoni Villaverde and U18. Nanotoxicology Unit, Ramón Mangues, together with Esther Vázquez and Manuel Rodriguez, was awarded with the First Prize.
Nanoligent´s project is about antimetastatic medication for colorectal cancer and its business model is carrying out a first clinical trial which demonstrates the efficacy of the medication in humans and allows the company to sign a license agreement with a pharmaceutical company.
